SPINT2 Gene Diarrhea type 3 secretory sodium congenital syndromic Genetic Test
Test Details
The SPINT2 gene is associated with a condition called Diarrhea type 3, secretory sodium, congenital, syndromic. This genetic test is a Next-Generation Sequencing (NGS) test that analyzes the SPINT2 gene for any mutations or variations that may be present.
Diarrhea type 3, secretory sodium, congenital, syndromic is a rare genetic disorder that affects the intestines and causes chronic diarrhea. This condition is typically present from birth and is characterized by excessive secretion of sodium in the intestines, leading to the loss of water and electrolytes and resulting in diarrhea.
The NGS genetic test for SPINT2 gene mutations can help in the diagnosis of this condition. It involves sequencing the DNA of an individual to identify any changes or variations in the SPINT2 gene that may be responsible for the disorder. This test can provide valuable information for healthcare professionals in determining the underlying cause of the symptoms and guiding appropriate treatment options.
It is important to note that this genetic test is specific to the SPINT2 gene and may not detect mutations in other genes that could also cause similar symptoms. Genetic counseling is recommended for individuals considering this test to better understand the implications and limitations of the results.
Test Name
SPINT2 Gene Diarrhea type 3 secretory sodium congenital syndromic Genetic Test
Components
Price: 4400.0 AED
Sample Condition
Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery
3 to 4 Weeks
Method
NGS Technology
Test Type
Metabolic Disorders
Doctor
General Physician
Test Department
Genetics
Pre Test Information
Clinical History of Patient who is going for SPINT2 Gene Diarrhea type 3, secretory sodium, congenital, syndromic NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with Diarrhea type 3, secretory sodium, congenital, syndromic
| Test Name | SPINT2 Gene Diarrhea type 3 secretory sodium congenital syndromic Genetic Test |
|---|---|
| Components | |
| Price | 4400.0 AED |
| Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
| Report Delivery | 3 to 4 Weeks |
| Method | NGS Technology |
| Test type | Metabolic Disorders |
| Doctor | General Physician |
| Test Department: | Genetics |
| Pre Test Information | Clinical History of Patient who is going for SPINT2 Gene Diarrhea type 3, secretory sodium, congenital, syndromic NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with Diarrhea type 3, secretory sodium, congenital, syndromic |
| Test Details |
The SPINT2 gene is associated with a condition called Diarrhea type 3, secretory sodium, congenital, syndromic. This genetic test is a Next-Generation Sequencing (NGS) test that analyzes the SPINT2 gene for any mutations or variations that may be present. Diarrhea type 3, secretory sodium, congenital, syndromic is a rare genetic disorder that affects the intestines and causes chronic diarrhea. This condition is typically present from birth and is characterized by excessive secretion of sodium in the intestines, leading to the loss of water and electrolytes and resulting in diarrhea. The NGS genetic test for SPINT2 gene mutations can help in the diagnosis of this condition. It involves sequencing the DNA of an individual to identify any changes or variations in the SPINT2 gene that may be responsible for the disorder. This test can provide valuable information for healthcare professionals in determining the underlying cause of the symptoms and guiding appropriate treatment options. It is important to note that this genetic test is specific to the SPINT2 gene and may not detect mutations in other genes that could also cause similar symptoms. Genetic counseling is recommended for individuals considering this test to better understand the implications and limitations of the results. |
